Clinical Trial Update: Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating chemotherapy plus atezolizumab for extensive-stage small cell lung cancer with untreated asymptomatic brain metastases has been te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Jeffrey Clarke | Conditions: Small-cell Lung Cancer, Brain Metastases | Phase 2 | Status: TERMINATED | Results posted: 2024-03-13